8:30 am Registration & Virtual Morning Coffee

Harnessing New Technology

9:00 am Chair’s Opening Address

9:10 am Optimizing R&D Costs with Machine Learning: How A Big Pharma Diagnoses & Improves Research Efficiency with AI-Assisted Reagent Selection

  • Deborah Franco Global Sourcing Manager Scientific Services , Novartis

Synopsis

• Innovation driven by technology: how machine learning is optimizing reagent selection and reducing the burden of selection and validation. Initial situation and challenges

• Unlocking value with AI: Operational efficiencies, reducing search time, avoiding waste, accelerating science

• Transformation and expansion: how the positive results have led to into the project expansion and  collaboration

9:30 am Case Study on Supplier Spend Analytics for Clinical Trials

  • Aaron Nolan Consultant, Clinical Labs and Diagnostic Technologies, Eli Lilly and Company

9:50 am Live Q&A – Ask the Panel Your Burning Questions

10:10 am Buyer-Focused Private Marketplace Procurement: How Novel Solutions Are Shifting Power to Buyers While Aligning the Interests of Both Buyer & Supplier?

Synopsis

  • Benefits, limitations and history of hosted catalogs, Level 1 and Level 2 punchouts
  • Overview of new emerging models for procurement from new distributor models to marketplaces
  • Evaluation of model maturity from a customer experience, analytics, pricing, and supplier management perspectives
  • How new offerings are leveraging intelligent agents and powerful analytics to enhance the power of buyers and the effectiveness of suppliers

10:40 am Models, challenges and Triumphs of a Virtual Trial

Synopsis

  • The benefits and lessons learned of virtual trials
  • How to tackle patient buy-in and support virtual trials in order to expedite speed to market

11:00 am Live Q&A – Ask the Panel Your Burning Questions

11:20 am Speed Networking

11:45 am Coffee Break

Synopsis

• Visit Our Partners’ Booths in the Virtual Exhibition Hall
• 121 Meetings

12:00 pm Effects of Covid-19 on Procurement and Sourcing

Synopsis

• Global sourcing to manage supply chain risk with diminished supply
• Remote management of trials and studies
• Procurement of PPE for reopening of labs

12:45 pm Program Partner: LexisNexis

  • Erin Benson Director Market Planning , LexisNexis Risk Solutions

1:15 pm Networking Lunch

Strategic Sourcing

2:15 pm Strategic Sourcing for Rare Diseases & Emerging Therapeutics

Synopsis

• How to use in-sourcing as an effective strategy
• Key considerations when selecting a CMO in rare disease / gene therapy

2:35 pm Importance of Pre-Emptive Thinking in Procurement of NHP’s for Ultimate Product Approval

  • Gerard Cardillo Executive Director Global Categories Procurement, Charles River Labs

Synopsis

• As R&D continues to increase investment into large molecule drug products, safe, ethical and timely procurement of non-human primates has never been so important
• Challenges associated with R&D procurement for large molecule with respect to NHP’s, including predicting pricing, availability, lead time to sexual maturity and how to engage the market • How to overcome these challenges and minimize an often time-consuming barrier in getting to PoC human clinical trials

2:55 pm Technology Booms In Business Operations; A Case Study in RFP Automation

  • Farah Ahmad Chief Commercial Officer , Clinical Maestro

3:25 pm Live Q&A – Ask the Panel Your Burning Questions

3:55 pm Afternoon Tea

4:30 pm Proven Technology Driven Clinical Trial Supply Alternative

  • Tom Heck Senior Vice President, Clinical Trial Services, TrialCard

Synopsis

  • Learn about an innovative and more efficient strategy that is changing the paradigm of clinical trial supply
  • Understand how the alternative strategy saves time, money, mitigates risks and reduces clinical trial supply hassles
  • Hear real-life case studies proving time and resource savings
  • See how meeting the target “Study Start” and “First Patient In” date is more easily accomplished

4:45 pm Speaker Interview Followed by Debate: Single vs Dual vs TriSourcing – How Takeda Realigned their Sourcing Strategy Post Shire Acquisition

  • Wanlu Liu Global Lead Sourcing Manager, Takeda
  • Rinaldo Dorman Senior Manager, R&D Global Procurement & Strategic Sourcing , Sarepta Therapeutics

Synopsis

• Rinaldo Doorman (former Shire clinical category lead) interviews Wanlu Liu, Global lead Sourcing Manager, Takeda, on the organisational changes within Takeda post Shire acquisition

Debate: Post M&A: How to Re-Align and Ensure Smooth Integration

• With M&A on the rise we look at how to keep the best parts of both companies
• How to tackle “winner takes all” scenario and challenges with integration

5:05 pm Live Q&A – Ask the Panel Your Burning Questions

5:25 pm Chair’s Closing Remarks

5:30 pm Close of Day 1